Patent · US Expired

Pharmaceutical composition based on a polymorphic form I of idazoxan

US7338970B2 · kind B2 · utility

1Cited by

3References

2Claims

0Family size

Assignee

PIERRE FABRE MÉDICAMENT · FR

Inventors

Joel Bougaret · Francarville, FR
Jean-Louis Avan · Auterive, FR
Roland Segonds · Toulouse, FR

Key dates

Filing date	Nov 28, 2003
Grant date	Mar 4, 2008
Priority date	—
Expiry date	Mar 6, 2025

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Pharmaceutical composition comprising 5 to 20% of an idazoxan salt or of idazoxan hydrate, 10 to 40% of microcrystalline cellulose, 1 to 5% of lubricant, 0.1 to 0.5% of colloidal silica and from 29.5% to 84.8% of lactose, with respect to the total mass.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.